Head-To-Head Comparison: Schrodinger (NASDAQ:SDGR) and Dialogue Health Technologies (OTCMKTS:DLHTF)
by Amy Steele · The Cerbat GemDialogue Health Technologies (OTCMKTS:DLHTF – Get Free Report) and Schrodinger (NASDAQ:SDGR – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.
Analyst Ratings
This is a breakdown of current ratings for Dialogue Health Technologies and Schrodinger, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Dialogue Health Technologies | 0 | 0 | 0 | 0 | 0.00 |
| Schrodinger | 1 | 3 | 3 | 0 | 2.29 |
Schrodinger has a consensus price target of $20.50, indicating a potential upside of 16.54%. Given Schrodinger’s stronger consensus rating and higher probable upside, analysts plainly believe Schrodinger is more favorable than Dialogue Health Technologies.
Institutional & Insider Ownership
79.1% of Schrodinger shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Profitability
This table compares Dialogue Health Technologies and Schrodinger’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Dialogue Health Technologies | N/A | N/A | N/A |
| Schrodinger | -20.98% | -16.37% | -8.19% |
Earnings & Valuation
This table compares Dialogue Health Technologies and Schrodinger”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Dialogue Health Technologies | N/A | N/A | N/A | N/A | N/A |
| Schrodinger | $259.04 million | 5.01 | -$103.26 million | ($0.74) | -23.77 |
Dialogue Health Technologies has higher earnings, but lower revenue than Schrodinger.
Summary
Schrodinger beats Dialogue Health Technologies on 6 of the 9 factors compared between the two stocks.
About Dialogue Health Technologies
Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada, the United Kingdom, Germany, and Internationally. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists. The company's platform also enables its members and their dependents to access employee assistance program. Dialogue Technologies Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.
About Schrodinger
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.